{"id":"W2125643269","doi":"10.1023/a:1008382516636","title":"Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse","year":2001,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":372,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"University of California, San Francisco","keywords":"Medicine; Temozolomide; Internal medicine; Clinical endpoint; Phases of clinical research; Chemotherapy; Lomustine; Population; Progression-free survival; Surgery; Oncology; Gliosarcoma; Progressive disease; Clinical trial; Glioblastoma; Vincristine; Cyclophosphamide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001375008,0.001552185,0.002631325,0.0003902434,0.0004303261,0.0008032037,0.0008605878,0.0009356661,0.002705111],"category_scores_gemma":[0.0008786705,0.0004638079,0.001140718,0.0004317925,0.0009493075,0.0009200086,0.0003903106,0.002657691,0.0005727341],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001432785,"about_ca_system_score_gemma":0.001702411,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002698348,"about_ca_topic_score_gemma":0.007652027,"domain_scores_codex":[0.9997045,0.0001439468,0.00001064728,0.00004964248,0.00001681708,0.00007439849],"domain_scores_gemma":[0.9994764,0.00008147659,0.00009871613,0.00003780866,0.00003152246,0.000274063],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8850706,0.01604757,0.005683048,0.0006865804,0.001753223,0.000171515,0.0003387093,0.002427285,0.015536,0.0004504564,0.007719465,0.06411547],"study_design_scores_gemma":[0.8010756,0.1819992,0.01084144,0.00003861701,0.0005644368,0.0002425097,0.0001160155,0.001113061,0.001764392,0.0003323082,0.001880468,0.0000318092],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9944681,0.001933177,0.000302213,0.0008337841,0.0001904852,0.0006146376,0.0007761201,0.00005818598,0.000823229],"genre_scores_gemma":[0.9908739,0.001960818,0.0008810585,0.0006878296,0.0001619549,0.001219901,0.002053943,0.00003175951,0.002128896],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002705111,"threshold_uncertainty_score":0.01039571,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03575505135581412,"score_gpt":0.3477511933093104,"score_spread":0.3119961419534962,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}